BlackRock’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $95.9M | Buy |
6,843,733
+92,822
| +1% | +$1.25M | ﹤0.01% | 2137 |
|
|
2025
Q4 | $75.8M | Sell |
6,750,911
-82,860
| -1% | -$948K | ﹤0.01% | 2270 |
|
|
2025
Q3 | $79M | Buy |
6,833,771
+4,457
| +0.1% | +$52.2K | ﹤0.01% | 2241 |
|
|
2025
Q2 | $83.6M | Sell |
6,829,314
-67,654
| -1% | -$851K | ﹤0.01% | 2163 |
|
|
2025
Q1 | $98.8M | Sell |
6,896,968
-254,859
| -4% | -$3.98M | ﹤0.01% | 1997 |
|
|
2024
Q4 | $114M | Buy |
7,151,827
+104,639
| +1% | +$2.07M | ﹤0.01% | 2004 |
|
|
2024
Q3 | $169M | Buy |
7,047,188
+35,969
| +0.5% | +$822K | ﹤0.01% | 1761 |
|
|
2024
Q2 | $140M | Sell |
7,011,219
-248,055
| -3% | -$4.83M | ﹤0.01% | 1836 |
|
|
2024
Q1 | $145M | Sell |
7,259,274
-202,069
| -3% | -$3.91M | ﹤0.01% | 1846 |
|
|
2023
Q4 | $167M | Buy |
7,461,343
+327,866
| +5% | +$6.77M | ﹤0.01% | 1761 |
|
|
2023
Q3 | $144M | Sell |
7,133,477
-164,627
| -2% | -$3.73M | ﹤0.01% | 1766 |
|
|
2023
Q2 | $187M | Sell |
7,298,104
-160,472
| -2% | -$4.23M | 0.01% | 1629 |
|
|
2023
Q1 | $222M | Sell |
7,458,576
-112,472
| -1% | -$3.27M | 0.01% | 1466 |
|
|
2022
Q4 | $205M | Buy |
7,571,048
+189,466
| +3% | +$4.63M | 0.01% | 1514 |
|
|
2022
Q3 | $161M | Sell |
7,381,582
-229,542
| -3% | -$6M | 0.01% | 1637 |
|
|
2022
Q2 | $208M | Sell |
7,611,124
-3,012
| -0% | -$86.5K | 0.01% | 1498 |
|
|
2022
Q1 | $255M | Buy |
7,614,136
+688
| +0% | +$22.2K | 0.01% | 1487 |
|
|
2021
Q4 | $264M | Buy |
7,613,448
+319,548
| +4% | +$10.3M | 0.01% | 1530 |
|
|
2021
Q3 | $228M | Sell |
7,293,900
-78,594
| -1% | -$2.67M | 0.01% | 1619 |
|
|
2021
Q2 | $268M | Buy |
7,372,494
+1,761,426
| +31% | +$72.8M | 0.01% | 1552 |
|
|
2021
Q1 | $245M | Buy |
5,611,068
+287,727
| +5% | +$13.5M | 0.01% | 1591 |
|
|
2020
Q4 | $244M | Buy |
5,323,341
+177,432
| +3% | +$7.39M | 0.01% | 1466 |
|
|
2020
Q3 | $171M | Sell |
5,145,909
-201,136
| -4% | -$6.43M | 0.01% | 1504 |
|
|
2020
Q2 | $157M | Sell |
5,347,045
-73,430
| -1% | -$2.13M | 0.01% | 1528 |
|
|
2020
Q1 | $146M | Sell |
5,420,475
-131,283
| -2% | -$3.92M | 0.01% | 1385 |
|
|
2019
Q4 | $187M | Sell |
5,551,758
-28,427
| -0.5% | -$1.03M | 0.01% | 1555 |
|
|
2019
Q3 | $209M | Buy |
5,580,185
+114,453
| +2% | +$4.37M | 0.01% | 1372 |
|
|
2019
Q2 | $238M | Buy |
5,465,732
+23,000
| +0.4% | +$984K | 0.01% | 1294 |
|
|
2019
Q1 | $232M | Buy |
5,442,732
+1,436
| +0% | +$64.3K | 0.01% | 1296 |
|
|
2018
Q4 | $244M | Buy |
5,441,296
+177,524
| +3% | +$9.3M | 0.01% | 1168 |
|
|
2018
Q3 | $361M | Buy |
5,263,772
+82,497
| +2% | +$5.31M | 0.02% | 1023 |
|
|
2018
Q2 | $297M | Buy |
5,181,275
+186,145
| +4% | +$9.84M | 0.01% | 1120 |
|
|
2018
Q1 | $230M | Buy |
4,995,130
+52,167
| +1% | +$2.48M | 0.01% | 1252 |
|
|
2017
Q4 | $228M | Sell |
4,942,963
-293,692
| -6% | -$13.5M | 0.01% | 1271 |
|
|
2017
Q3 | $236M | Sell |
5,236,655
-61,947
| -1% | -$2.64M | 0.01% | 1212 |
|
|
2017
Q2 | $208M | Sell |
5,298,602
-640,750
| -11% | -$24.2M | 0.01% | 1275 |
|
|
2017
Q1 | $226M | Buy |
5,939,352
+5,847,442
| +6,362% | +$228M | 0.01% | 1177 |
|
|
2016
Q4 | $3.4M | Sell |
91,910
-5,666
| -6% | -$203K | ﹤0.01% | 1042 |
|
|
2016
Q3 | $3.38M | Buy |
97,576
+11,904
| +14% | +$417K | ﹤0.01% | 1025 |
|
|
2016
Q2 | $2.79M | Sell |
85,672
-852
| -1% | -$26.1K | ﹤0.01% | 1029 |
|
|
2016
Q1 | $2.48M | Sell |
86,524
-6,278
| -7% | -$167K | ﹤0.01% | 1043 |
|
|
2015
Q4 | $3.1M | Buy |
92,802
+64,230
| +225% | +$2M | ﹤0.01% | 948 |
|
|
2015
Q3 | $812K | Sell |
28,572
-115,828
| -80% | -$4.04M | ﹤0.01% | 1361 |
|
|
2015
Q2 | $5.85M | Sell |
144,400
-50,568
| -26% | -$2.27M | 0.01% | 798 |
|
|
2015
Q1 | $9.59M | Sell |
194,968
-11,052
| -5% | -$512K | 0.01% | 693 |
|
|
2014
Q4 | $9.37M | Buy |
+206,020
| New | +$8.09M | 0.01% | 696 |
|
Other funds holding AVNS
AC
VCM
VPM
BCM
BlackRock's AVNS Position: Q1 2026 in Review
BlackRock increased its Avanos Medical (AVNS) stake by 1.4% in Q1 2026, buying an estimated $1.25M and bringing the position to 6,843,733 shares worth $95.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2137.
BlackRock first reported a position in AVNS in Q4 2014 and has held it in 46 quarters since. The position peaked at $361M in Q3 2018. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.
- BlackRock held 6,843,733 shares of Avanos Medical worth $95.9M as of Q1 2026.
- BlackRock bought 92,822 Avanos Medical shares in Q1 2026, an estimated $1.25M.
- Avanos Medical made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #2137 holding.
- BlackRock first reported a position in Avanos Medical in Q4 2014 and has held it in 46 quarters since.
- BlackRock's Avanos Medical position peaked at $361M in Q3 2018.
- 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.